Chlamydia pneumoniae, asthma, and COPD: what is the evidence? (Q33763030)

29 July 2017

1 reference

title

Chlamydia pneumoniae, asthma, and COPD: what is the evidence? (English)

1 reference

chronic obstructive pulmonary disease

29 July 2017

main subject

1 reference

1 reference

Chlamydia pneumoniae

1 reference

Hahn DL

1

1 reference

29 July 2017

publication date

1 October 1999

1 reference

Annals of Allergy, Asthma & Immunology

29 July 2017

published in

1 reference

29 July 2017

volume

83

1 reference

29 July 2017

issue

4

1 reference

29 July 2017

page(s)

271-88, 291; quiz 291-2

1 reference

Infections caused by Chlamydia pneumoniae strain TWAR

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Chlamydia pneumoniae and its role in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

The relationship of the etiologic factors in asthma in infants and children

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Asthma and wheezing in the first six years of life. The Group Health Medical Associates

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Adenoviral infection and childhood asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

The association of Chlamydia pneumoniae infection and reactive airway disease in children

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Evidence for Chlamydia pneumoniae infection in steroid-dependent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Can acute Chlamydia pneumoniae respiratory tract infection initiate chronic asthma?

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Acute exacerbations of asthma in adults: role of Chlamydia pneumoniae infection

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Inhibition of Chlamydia pneumoniae replication in HEp-2 cells by interferon-gamma: role of tryptophan catabolism.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Detection of Chlamydia trachomatis deoxyribonucleic acid in women with tubal infertility.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Antibody response to the 60-kDa chlamydial heat-shock protein is associated with scarring trachoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Antibody to chlamydial hsp60 predicts an increased risk for chlamydial pelvic inflammatory disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

T helper type-1 (Th1)/Th2 profiles of peripheral blood mononuclear cells (PBMC); responses to antigens of Chlamydia trachomatis in subjects with severe trachomatous scarring.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Persistent infection with Chlamydia pneumoniae following acute respiratory illness

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Serum gamma-interferon in patients with pneumonia caused by Chlamydia pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Ultrastructural lung pathology of experimental Chlamydia pneumoniae pneumonitis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Reactivation of Chlamydia pneumoniae lung infection in mice by cortisone

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Experimental Chlamydia pneumoniae infection in mice: effect of reinfection and passive immunization

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Chlamydia pneumoniae infection induces inflammatory changes in the aortas of rabbits.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia in children

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Mycoplasma pneumoniae Disease: Clinical Spectrum, Pathophysiology, Epidemiology, and Control

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Persistent Chlamydia pneumoniae infection in a Swedish family

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Interaction of Chlamydia pneumoniae and human alveolar macrophages: infection and inflammatory response

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Myocarditis caused by Chlamydia pneumoniae (TWAR) and sudden unexpected death in a Swedish elite orienteer.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Chlamydia pneumoniae--a new causative agent of reactive arthritis and undifferentiated oligoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

1 reference

7 January 2021

Lumbosacral meningoradiculitis associated with Chlamydia pneumoniae infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Pneumonia due to Chlamydia pneumoniae: prevalence, clinical features, diagnosis, and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Clinical picture of community-acquired Chlamydia pneumoniae pneumonia requiring hospital treatment: a comparison between chlamydial and pneumococcal pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Role and contribution of viral respiratory infections to asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Chlamydia pneumoniae-induced ciliostasis in ciliated bronchial epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Detection of anti-Chlamydia pneumoniae IgE in children with reactive airway disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Association of Chlamydia pneumoniae IgA antibodies with recently symptomatic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Increased expression of heat shock protein 70 on airway cells in asthma and chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Regulation of IgE production in pre-sensitized animals: in vivo elimination of alveolar macrophages preferentially increases IgE responses to inhaled allergen*

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Lipopolysaccharide augments IgG and IgE responses of mice to the latex allergen Hev b 5

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Use of HL cells for improved isolation and passage of Chlamydia pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Factors affecting viability and growth in HeLa 229 cells of Chlamydia sp. strain TWAR

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Prevalence of Chlamydia pneumoniae in healthy children and in children with respiratory tract infections

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Demonstration of Chlamydia pneumoniae in patients with chronic pharyngitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

A reverse transcriptase-PCR based assay for in-vitro antibiotic susceptibility testing of Chlamydia pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Rapid diagnosis of respiratory Chlamydia pneumoniae infection by nested touchdown polymerase chain reaction compared with culture and antigen detection by EIA.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Rapid detection of Chlamydia pneumoniae by PCR-enzyme immunoassay.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Polymerase chain reaction for detection of Chlamydia pneumoniae in gargled-water specimens of children

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

A clinical and epidemiological study of "ornithosis" caused by Chlamydia psittaci and Chlamydia pneumoniae (strain TWAR).

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Circulating immune complexes containing chlamydial lipopolysaccharide in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Chlamydia pneumoniae, strain TWAR.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

The role of atypical pathogens: Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella pneumophila in respiratory infection

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Chlamydia pneumoniae strain TWAR, Mycoplasma pneumoniae, and viral infections in acute respiratory disease in a university student health clinic population

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Respiratory infection with Chlamydia pneumoniae in middle-aged and older adult outpatients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

An epidemic of infections due to Chlamydia pneumoniae in military conscripts

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Antibody response to Chlamydia pneumoniae infection in children with respiratory illness

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Chlamydia pneumoniae infections.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Antichlamydial antimicrobial therapy for asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Chronic Chlamydia pneumoniae Infection as a Risk Factor for Coronary Heart Disease in the Helsinki Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Chlamydia pneumoniae and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Chronic Chlamydia pneumoniae infection and asthma exacerbations in children

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Susceptibility of Chlamydia pneumoniae to azithromycin and doxycycline: methodological aspects on the determination of minimal inhibitory and minimal bactericidal concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Chlamydia pneumoniae.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Lower respiratory tract infection with Chlamydia pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Chlamydia pneumoniae (TWAR) infection in Tanzanian children

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Prevalence of asymptomatic nasopharyngeal carriage of Chlamydia pneumoniae in subjectively healthy adults: assessment by polymerase chain reaction-enzyme immunoassay and culture

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Endemic prevalence of Chlamydia pneumoniae in subjectively healthy persons

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Bacterial infection in under school age children with expiratory difficulty

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Chlamydial infection and reactive airway disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Serology of chlamydia in relation to asthma and bronchial hyperresponsiveness

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Chlamydia pneumoniae and asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Chlamydia pneumoniae and asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Regional variation in ischemic heart disease: a possible missing risk factor?

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

A seroepidemiologic study of Chlamydia pneumoniae in Rhode Island. Evidence of serologic cross-reactivity

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Chlamydia pneumoniae, Strain TWAR, Infection in Patients with Chronic Obstructive Pulmonary Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

1 reference

7 January 2021

Chlamydia pneumoniae infection in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Chlamydia pneumoniae and exacerbations of asthma in adults

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Importance of smoking for Chlamydia pneumoniae seropositivity

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

High prevalence of antibodies to Chlamydia pneumoniae; determinants of IgG and IgA seropositivity among Jerusalem residents

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Chlamydia pneumoniae antibodies in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

Chlamydia pneumoniae infection in patients with diffuse panbronchiolitis and COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962666-X

7 January 2021

10.1016/S1081-1206(10)62666-X

Identifiers

DOI

1 reference

29 July 2017

1 reference